Dec 20, 2024 · The pharmaceutical industry is undergoing a transformative era, driven by groundbreaking advancements in technology, shifting consumer expectations, and an …

The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% complete response in patients with Bacillus Calmette …

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in …

Oct 2, 2024 · In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, …

Your advertising is all about health care. Our judges are all from health care — doctors, nurses, thought leaders, patients and more. If you want to know what impact your work has on these …

Sep 19, 2024 · Field medical education before launch is linked to greater launch success, improving treatment adoption by up to 50%. New data also finds that biopharmas investing in …

Nov 11, 2016 · Crown Prince: In contrast, Novo Nordisk anoints a new product leader every few years in its world-leading diabetes portfolio. For example, Novo’s GLP-1 agent Victoza has …

Aug 16, 2024 · In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, …

Aug 2, 2024 · Integrated Delivery Networks have changed the healthcare landscape over the past decade. Greg Skalicky, president and chief revenue officer at EVERSANA, spoke with …